Literature DB >> 22376031

Converting peptides into drug leads by lipidation.

L Zhang1, G Bulaj.   

Abstract

Lipidation is a posttranslational modification of proteins that has also found its use in designing peptide drugs. The presence of a lipid group in peptides modulates their hydrophobicity, secondary structures and self-assembling propensities while retaining their abilities to bind to target receptors. Lipidation improves peptides' metabolic stability, membrane permeability, bioavailability, and changes peptides' pharmacokinetic and pharmacodynamic properties. Herein, we review the applications of various lipidation strategies in peptide drug design, the effects of the chain length and anchor position of fatty acids in peptide lipidation, the physicochemical and biological properties of selected lipidated peptides and the synthesis strategies for peptide lipidation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22376031     DOI: 10.2174/092986712799945003

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  44 in total

1.  Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.

Authors:  Veronika Mäde; Kathrin Bellmann-Sickert; Anette Kaiser; Jens Meiler; Annette G Beck-Sickinger
Journal:  ChemMedChem       Date:  2014-08-22       Impact factor: 3.466

2.  Post-Translational Tyrosine Geranylation in Cyanobactin Biosynthesis.

Authors:  Maho Morita; Yue Hao; Jouni K Jokela; Debosmita Sardar; Zhenjian Lin; Kaarina Sivonen; Satish K Nair; Eric W Schmidt
Journal:  J Am Chem Soc       Date:  2018-05-01       Impact factor: 15.419

3.  Molecular basis for the broad substrate selectivity of a peptide prenyltransferase.

Authors:  Yue Hao; Elizabeth Pierce; Daniel Roe; Maho Morita; John A McIntosh; Vinayak Agarwal; Thomas E Cheatham; Eric W Schmidt; Satish K Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

4.  Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer.

Authors:  Himgauri Naik; Ted Gauthier; Sitanshu Singh; Seetharama Jois
Journal:  Bioorg Med Chem Lett       Date:  2018-10-03       Impact factor: 2.823

5.  Small cyclic agonists of iron regulatory hormone hepcidin.

Authors:  Kristine Chua; Eileen Fung; Ewa D Micewicz; Tomas Ganz; Elizabeta Nemeth; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-03-12       Impact factor: 2.823

6.  Position of lipidation influences anticancer activity of Smac analogs.

Authors:  Ewa D Micewicz; Christine Nguyen; Alina Micewicz; Alan J Waring; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2019-04-26       Impact factor: 2.823

7.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

Review 8.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

9.  Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain.

Authors:  Jamie R Doyle; Subrahmanian T Krishnaji; Guangli Zhu; Zhen-Zhong Xu; Daniel Heller; Ru-Rong Ji; Bruce D Levy; Krishna Kumar; Alan S Kopin
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

10.  Isolation of Positive Modulator of Glucagon-like Peptide-1 Signaling from Trigonella foenum-graecum (Fenugreek) Seed.

Authors:  Klim King; Nai-Pin Lin; Yu-Hong Cheng; Gao-Hui Chen; Rong-Jie Chein
Journal:  J Biol Chem       Date:  2015-09-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.